Pfizer

YTD

ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.

CEO

Albert Bourla

CEOAlbert Bourla

Employees

81,000

Employees81,000

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1849

Founded1849

Employees

81,000

Employees81,000

PFE Key Statistics

Market cap

132.67B

Market cap132.67B

Price-Earnings ratio

16.92

Price-Earnings ratio16.92

Dividend yield

7.28%

Dividend yield7.28%

Average volume

34.76M

Average volume34.76M

High today

$23.58

High today$23.58

Low today

$23.15

Low today$23.15

Open price

$23.25

Open price$23.25

Volume

30.43M

Volume30.43M

52 Week high

$31.54

52 Week high$31.54

52 Week low

$20.92

52 Week low$20.92

PFE News

Simply Wall St 3d

Pfizer Exceeds Sales Milestone With Cresemba In Asia Pacific And China

announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, marking significant growth in key Asian markets. Despite...

The Motley Fool 3d

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or inv...

The Motley Fool 3d

Here Are All 6 Stocks I've Bought Through 5 Months of 2025

A volatile stock market represents an ideal opportunity for long-term investors to pounce. It's been a wild ride for the stock market through the first five mo...

Analyst ratings

58%

of 26 ratings

Buy

38.5%

Hold

57.7%

Sell

3.8%

More PFE News

The Motley Fool 7d

Terrible News for Pfizer Stock Investors

The past three years have been challenging for Pfizer (PFE 0.11%). Revenue and earnings have moved in the wrong direction, as has the company's share price. The...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.